Exercise-Induced Bronchospasm Withdrawn Phase 3 Trials for Arformoterol (DB01274)

Also known as: Exercise Induced Bronchospasm / Exercise-Induced Bronchoconstriction / Bronchospasm, Exercise-Induced / Exercise Induced Bronchoconstriction / Exercise induced bronchospasm (disorder) / Spasm bronchial / Bronchial Spasm / (Bronchospasm) or (O/E - rhonchi (& present)) / Bronchospasm (finding) / Bronchospasm / Bronchospasm NOS

IndicationStatusPhase
DBCOND0035673 (Exercise-Induced Bronchospasm)Withdrawn3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00662779Bronchoprotective Effect of Arformoterol in Children With Exercise-Induced Bronchospasm (EIB)Prevention